These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15869008)

  • 1. Cardiovascular effects of aldosterone.
    Murin J
    Bratisl Lek Listy; 2005; 106(1):3-19. PubMed ID: 15869008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eplerenone: cardiovascular protection.
    Brown NJ
    Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
    Leopold JA
    Circulation; 2011 Nov; 124(18):e466-8. PubMed ID: 22042931
    [No Abstract]   [Full Text] [Related]  

  • 4. Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.
    Young MJ; Funder JW
    J Hypertens; 2002 Aug; 20(8):1465-8. PubMed ID: 12172301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular action of aldosterone].
    Miyamori I; Kawai Y; Fan CY
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():40-5. PubMed ID: 16895168
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.
    Dawson A; Davies JI; Struthers AD
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886
    [No Abstract]   [Full Text] [Related]  

  • 8. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular actions of aldosterone.
    Briet M; Schiffrin EL
    J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone and antialdosterone therapy in congestive heart failure.
    Weber KT; Villarreal D
    Am J Cardiol; 1993 Jan; 71(3):3A-11A. PubMed ID: 8422002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of aldosterone receptor blockade in the management of cardiovascular disease.
    Liew D; Krum H
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone receptor antagonists.
    Azizi M
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):179-181. PubMed ID: 32473789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone inhibition and cardiovascular protection: more important than it once appeared.
    Martinez FA
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):345-50. PubMed ID: 20676926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone and aldosterone antagonism in systemic hypertension.
    Frishman WH; Stier CT
    Curr Hypertens Rep; 2004 Jun; 6(3):195-200. PubMed ID: 15128471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone and mineralocorticoid receptors in the cardiovascular system.
    Funder JW
    Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of aldosterone in the cardiovascular system.
    Rocha R; Funder JW
    Ann N Y Acad Sci; 2002 Sep; 970():89-100. PubMed ID: 12381544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Roll of aldosterone in pathogenesis of kidney disorders].
    Kitamura K; Tomita K
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1428-34. PubMed ID: 16097603
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldosterone target organ protection by eplerenone.
    Rudolph AE; Rocha R; McMahon EG
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for the use of aldosterone antagonists in congestive heart failure.
    Rocha R; Williams GH
    Drugs; 2002; 62(5):723-31. PubMed ID: 11929327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconsidering the roles of the mineralocorticoid receptor.
    Funder JW
    Hypertension; 2009 Feb; 53(2):286-90. PubMed ID: 19139379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.